NO20003767L - Monoklonalt antistoff anti-<alfa>v-integrin og dets anvendelse til inhibering av <alfa>v<beta>6-integrinbinding til fibronektin - Google Patents

Monoklonalt antistoff anti-<alfa>v-integrin og dets anvendelse til inhibering av <alfa>v<beta>6-integrinbinding til fibronektin

Info

Publication number
NO20003767L
NO20003767L NO20003767A NO20003767A NO20003767L NO 20003767 L NO20003767 L NO 20003767L NO 20003767 A NO20003767 A NO 20003767A NO 20003767 A NO20003767 A NO 20003767A NO 20003767 L NO20003767 L NO 20003767L
Authority
NO
Norway
Prior art keywords
alpha
integrin
inhibit
monoclonal antibody
antibody anti
Prior art date
Application number
NO20003767A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003767D0 (no
Inventor
Simon Goodman
Beate Diefenbach
Francesc Mitjans
Ana Carceller
Elisabet Rosell-Vives
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20003767D0 publication Critical patent/NO20003767D0/no
Publication of NO20003767L publication Critical patent/NO20003767L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20003767A 1998-01-23 2000-07-21 Monoklonalt antistoff anti-<alfa>v-integrin og dets anvendelse til inhibering av <alfa>v<beta>6-integrinbinding til fibronektin NO20003767L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98101108 1998-01-23
PCT/EP1999/000101 WO1999037683A1 (de) 1998-01-23 1999-01-11 ADHESION RECEPTOR BLOCKER FOR αV-INTEGRINS

Publications (2)

Publication Number Publication Date
NO20003767D0 NO20003767D0 (no) 2000-07-21
NO20003767L true NO20003767L (no) 2000-07-21

Family

ID=8231295

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003767A NO20003767L (no) 1998-01-23 2000-07-21 Monoklonalt antistoff anti-<alfa>v-integrin og dets anvendelse til inhibering av <alfa>v<beta>6-integrinbinding til fibronektin

Country Status (17)

Country Link
EP (1) EP1049718B1 (de)
JP (1) JP2002501086A (de)
KR (1) KR20010034327A (de)
CN (1) CN1168741C (de)
AR (1) AR014464A1 (de)
AT (1) ATE322508T1 (de)
AU (1) AU2716399A (de)
BR (1) BR9907218A (de)
CA (1) CA2319160A1 (de)
DE (1) DE69930723T2 (de)
HU (1) HUP0101151A3 (de)
ID (1) ID27810A (de)
NO (1) NO20003767L (de)
PL (1) PL341569A1 (de)
SK (1) SK10772000A3 (de)
WO (1) WO1999037683A1 (de)
ZA (1) ZA99453B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1176195B1 (de) 1999-04-09 2013-05-22 Kyowa Hakko Kirin Co., Ltd. Verfahren zur kontrolle der aktivität von immunologisch funktionellem molekül
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
EP1381384B1 (de) 2001-04-24 2011-05-25 Merck Patent GmbH KOMBINATIONSTHERAPIE MIT ANTIANGIOGENEN MITTELN UND TNFalpha
EP1414491A4 (de) 2001-07-09 2005-07-06 Elan Pharm Inc Verfahren zur hemmung der toxizität von amyloid
US7829087B2 (en) 2001-07-09 2010-11-09 Elan Pharmaceuticals, Inc. Methods of treating cognitive impairment
MXPA04008870A (es) 2002-03-13 2005-06-17 Biogen Idec Inc Anticuerpos anti-avb6.
CN102875681A (zh) * 2005-07-08 2013-01-16 拜奥根Idec马萨诸塞公司 抗-αvβ6抗体及其用途
EP1973569B1 (de) 2006-01-18 2013-05-22 Merck Patent GmbH Spezifische therapie mit integrin-liganden zur krebsbehandlung
AR060040A1 (es) 2006-03-21 2008-05-21 Genentech Inc Antagonistas de vefg y de alfa5 beta 1
CN101563105B (zh) 2006-07-10 2013-01-23 拜奥根Idec马萨诸塞公司 用于抑制smad4-缺陷癌症的组合物和方法
EP2064244B1 (de) 2006-08-03 2019-06-05 MedImmune Limited GEGEN alphaVbeta6 GERICHTETE ANTIKÖRPER UND IHRE VERWENDUNG
JP2010516645A (ja) 2007-01-18 2010-05-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌を治療するためのインテグリンリガンドを用いる特異的療法および薬剤
TWI547503B (zh) 2007-09-26 2016-09-01 建南德克公司 抗α5β1抗體、編碼其之核酸、包含其之組合物及其製造及使用方法
JP5637855B2 (ja) 2007-11-08 2014-12-10 ザ ジェネラル ホスピタル コーポレイション 蛋白尿症の治療のための方法及び組成物
AU2010229479B2 (en) 2009-03-25 2013-03-28 Genentech, Inc. Novel anti-alpha5beta1 antibodies and uses thereof
US20120130146A1 (en) 2009-05-25 2012-05-24 Merck Patent Gmbh Continuous administration of cilengitide in cancer treatments
CN105315370A (zh) * 2010-02-18 2016-02-10 加利福尼亚大学董事会 整合素αVβ8中和抗体
US10035860B2 (en) 2013-03-15 2018-07-31 Biogen Ma Inc. Anti-alpha V beta 6 antibodies and uses thereof
WO2014144466A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Anti-alpha v beta 6 antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0719859T3 (da) * 1994-12-20 2003-10-20 Merck Patent Gmbh Anti-alfa V-integrin monoklonalt antistof

Also Published As

Publication number Publication date
EP1049718B1 (de) 2006-04-05
HUP0101151A3 (en) 2004-06-28
SK10772000A3 (sk) 2001-01-18
WO1999037683A1 (de) 1999-07-29
DE69930723D1 (de) 2006-05-18
KR20010034327A (ko) 2001-04-25
EP1049718A1 (de) 2000-11-08
ZA99453B (en) 1999-07-21
ID27810A (id) 2001-04-26
CN1288469A (zh) 2001-03-21
AR014464A1 (es) 2001-02-28
HUP0101151A2 (hu) 2001-08-28
JP2002501086A (ja) 2002-01-15
NO20003767D0 (no) 2000-07-21
ATE322508T1 (de) 2006-04-15
BR9907218A (pt) 2000-10-24
CA2319160A1 (en) 1999-07-29
PL341569A1 (en) 2001-04-23
AU2716399A (en) 1999-08-09
CN1168741C (zh) 2004-09-29
DE69930723T2 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
NO20003767L (no) Monoklonalt antistoff anti-&lt;alfa&gt;v-integrin og dets anvendelse til inhibering av &lt;alfa&gt;v&lt;beta&gt;6-integrinbinding til fibronektin
DK0719859T3 (da) Anti-alfa V-integrin monoklonalt antistof
NO20016243L (no) Anti-&lt;alfa&gt;v-&lt;beta&gt;3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
EP1071458A4 (de) Humanisierter antikörper und dessen verwendungen
ID22957A (id) Senyawa dan penggunaannya
DK0724543T3 (da) Syntetisk, porøst, krystallinsk MCM-58, dets syntese og anvendelse
ID28990A (id) Herbisida-herbisida dengan urea aminofenilsulfonil asilasi
IL225633A0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
NO20005412L (no) FAP&lt;alfa&gt;-spesifikt antistoff med forbedret fremstilling derav
NO993487L (no) Utgangsbuffer
DE69411982D1 (de) Katalytische Zusammensetzung
MX210287B (es) Composicion de cemento con reduccion de contraccion
ID23059A (id) Seterika dan sikat kukus untuk penggunaan dalam bisnis
DE69332401D1 (de) Verbesserte ein- und mehrstufige FIFO-Entwürfe für Datenübertragungssynchronisiereinrichtungen
ID19325A (id) Komposisi katalitik yang berguna dalam reaksi fischer-tropsch
FI954521L (fi) Alkyyliglykosidi, sen käyttö puhdistustarkoituksiin sekä puhdistuskoostumus
EP0933131A4 (de) Dünne metallschicht für metallkatalysatorträger und metallkatalysator mit dünnermetallschicht
GT200000150A (es) Empleo de compuestos polihidroxilados y de agentes de deslizamiento de cadenas.
ID16796A (id) ANTIBODI ANTI-FAS REKOMBINAN DAN DNA-nya
DE60005514D1 (de) Dormanz-brechende zusammenstezung und deren verwendung
NO20020885D0 (no) &lt;alfa&gt;v&lt;beta&gt;3-integrininhibitorer
IT1303769B1 (it) Catalizzatore e suo impiego per la sintesi di polioli polieteri.
NO20016341D0 (no) Inhibitorer for integrinet &lt;alfa&gt;v&lt;beta&gt;6
DE19980266D2 (de) CVD-Reaktor und dessen Verwendung
DK0853593T3 (da) Syntetisk, porøst, krystallinsk MCM-61, dets syntese og anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application